A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas
| Image |  |
|---|---|
| Description | scientific article published on 29 April 2019 |
| Author/s |
author: Axel Le Cesne Hans J. Gelderblom Robin L Jones Robert G. Maki |
| Publication date | April 29, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |